Stay updated on Pembrolizumab vs. EDP1503 in Melanoma Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab vs. EDP1503 in Melanoma Clinical Trial page.

Latest updates to the Pembrolizumab vs. EDP1503 in Melanoma Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedRevision: v3.4.2 has been added; the previous funding-status notice and Revision: v3.4.1 have been removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check21 days agoChange DetectedThe page now displays a site-wide notice about government funding and operating status, and the revision updated from v3.4.0 to v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check28 days agoChange DetectedAdded a 'Show glossary' option and updated various metadata labels related to results posting and QC criteria (e.g., Results First Posted, Last Update Posted, Last Update Submitted that Met QC Criteria, No FEAR Act Data). The revision tag changed from v3.3.4 to v3.4.0.SummaryDifference0.3%

- Check42 days agoChange DetectedRevision updated from v3.3.3 to v3.3.4; this appears to be an administrative update with no impact on study details or user-facing content. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check63 days agoChange DetectedA new Locations section is added showing the Chicago, Illinois site; the standalone Illinois Locations entry was removed, and the revision updated to v3.3.3.SummaryDifference0.2%

- Check71 days agoChange DetectedTwo timestamp labels in the Study Record Dates area were updated to include (Estimated), changing Results First Posted (Estimated) and Last Update Posted (Estimated). To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to Pembrolizumab vs. EDP1503 in Melanoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab vs. EDP1503 in Melanoma Clinical Trial page.